Stay updated on Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.
Latest updates to the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe Locations section was expanded to include numerous US states and international sites (e.g., New South Wales, South Australia, Victoria, Ontario, Quebec, Madrid), while the HHS Vulnerability Disclosure link was removed.SummaryDifference2%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study record shows a status change from 'No Results Posted' to 'Results Submitted' for NCT05041257.SummaryDifference0.0%
- Check34 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page; no substantive study information or user-facing features are affected.SummaryDifference0.0%
- Check42 days agoChange DetectedAdded that publications are automatically filled in from PubMed and may not relate to the study, and updated the revision to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check49 days agoChange DetectedRemoval of the government funding/operating status banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check63 days agoChange DetectedStudy locations have been updated, with new sites added across the United States and other countries and some existing sites removed. This changes the geographic availability of enrollment for the PICCOLO trial.SummaryDifference0.3%
Stay in the know with updates to Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.